New Gene Therapy Restores Hearing to Deaf Children via FDA Approval

The FDA has approved a new gene therapy that allows deaf children to hear again, marking a significant milestone in medical science. This breakthrough demonstrates the transformative potential of CRISPR technology to treat previously incurable genetic conditions. The approval signals a new era in healthcare where genetic editing can restore lost senses and improve quality of life.